Gene expression diagnostic company XDx raises $35.4M more
XDx, the startup behind a test measuring gene activity in the blood, is raising an additional $35.4 million in its fifth round of funding, according to VentureWire.
The Brisbane, Calif. company filed for an IPO of up to $86.3 million back in October, but has reportedly made a filing with the Securities and Exchange Commission saying it’s raising a fifth round of up to $61 million. It’s not clear who the new backers are.
The company received $25.6 million in the first part of this venture round back in May 2007.
Next Story: Invitation to DEMOPARTY for VentureBeat readers
Previous Story: Lucid Commerce raises $2.5M for business intelligence
About the Author, Anthony Ha
Anthony is VentureBeat's assistant editor, as well as its reporter on enterprise technology, cloud computing, and tech policy. Before joining VentureBeat in 2008, Anthony worked at the Hollister Free Lance, where he won awards from the California Newspaper Publishers Association for breaking news coverage and writing. He attended Stanford University and now lives in San Francisco. Reach him at anthony@venturebeat.com. You can also follow Anthony on Twitter.